New patent for the drug JAZZ XYWAV – DrugPatentWatch
[ad_1]
Annual Drug Patent Expiration for XYWAV
Xywav is a drug marketed by Jazz and included in one NDA. It is available from a single supplier. There are thirteen patents protecting this drug.
Drug patent litigation for XYWAV.
This drug has thirty-five patent family members in twenty-five countries.
The generic material in XYWAV is calcium oxybate; magnesium oxide; potassium oxybate; sodium oxybate. One registered supplier for this compound. Additional details are available on calcium oxybate; magnesium oxide; potassium oxybate; sodium oxybate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug JAZZ XYWAV
Related
[ad_2]
Source link
